Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Trial Comparing the Effect and Safety of Insulin Degludec Versus Insulin Detemir, Both in Combination With Insulin Aspart, in the Treatment of Pregnant Women With Type 1 Diabetes

NCT03377699 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT03377699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03377699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Trial Comparing the Effect and Safety of Insulin Degludec Versus Insulin Detemir, Both in Combination With Insulin Aspart, in the Treatment of Pregnant Women With Type 1 Diabetes
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
November 22, 2017
Completion date
December 17, 2020
Enrollment
225 (actual)
Sites
71

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 1